Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 2;56(1):2001494.
doi: 10.1183/13993003.01494-2020. Print 2020 Jul.

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

Frederikus A Klok  1   2 , Gudula J A M Boon  3 , Stefano Barco  2   4 , Matthias Endres  5   6 , J J Miranda Geelhoed  7 , Samuel Knauss  6 , Spencer A Rezek  8 , Martijn A Spruit  9   10   11 , Jörg Vehreschild  12   13   14 , Bob Siegerink  5   15
Affiliations

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

Frederikus A Klok et al. Eur Respir J. .

Abstract

An ordinal tool is proposed to measure the full spectrum of functional outcomes following COVID-19. This “Post-COVID-19 Functional Status (PCFS) scale” can be used for tracking functional status over time as well as for research purposes. https://bit.ly/3cofGaa

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: F.A. Klok reports grants from Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, MSD, Actelion, the Netherlands Thrombosis Foundation and the Dutch Heart Foundation, outside the submitted work. Conflict of interest: G.J.A.M. Boon has nothing to disclose. Conflict of interest: S. Barco has nothing to disclose. Conflict of interest: M. Endres reports grants from DFG under Germany's Excellence Strategy (EXC-2049; 390688087) and Bayer, and personal fees from Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Amgen, GSK, Sanofi, Covidien, Novartis and Pfizer, outside the submitted work. Conflict of interest: J.J.M. Geelhoed has nothing to disclose. Conflict of interest: S. Knauss has nothing to disclose. Conflict of interest: S.A. Rezek has nothing to disclose. Conflict of interest: M.A. Spruit reports grants from the Netherlands Lung Foundation and Stichting Astma Bestrijding, and grants and personal fees from AstraZeneca and Boehringer Ingelheim, outside the submitted work. Conflict of interest: J. Vehreschild has nothing to disclose. Conflict of interest: B. Siegerink has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Patient self-report methods for the Post-COVID-19 Functional Status (PCFS) scale. a) Flowchart. b) Patient questionnaire. Instructions for use: 1) to assess recovery after the SARS-CoV-2 infection, this PCFS scale covers the entire range of functional limitations, including changes in lifestyle, sports and social activities; 2) assignment of a PCFS scale grade concerns the average situation of the past week (exception: when assessed at discharge, it concerns the situation of the day of discharge); 3) symptoms include (but are not limited to) dyspnoea, pain, fatigue, muscle weakness, memory loss, depression and anxiety; 4) in case two grades seem to be appropriate, always choose the highest grade with the most limitations; 5) measuring functional status before the infection is optional; 6) alternatively to this flowchart and patient questionnaire, an extensive structured interview is available. The full manual for patients and physicians or study personnel is available from https://osf.io/qgpdv/ (free of charge).
See this image and copyright information in PMC

References

    1. Johns Hopkins University Coronavirus Resource Center. https://coronavirus.jhu.edu/ Date last accessed: April 2020.
    1. Simpson R, Robinson L. Rehabilitation after critical illness in people with COVID-19 infection. Am J Phys Med Rehabil 2020; 99: 470–474. doi:10.1097/PHM.0000000000001443 - DOI - PMC - PubMed
    1. Ngai JC, Ko FW, Ng SS, et al. . The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 2010; 15: 543–550. doi:10.1111/j.1440-1843.2010.01720.x - DOI - PMC - PubMed
    1. Tansey CM, Louie M, Loeb M, et al. . One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med 2007; 167: 1312–1320. doi:10.1001/archinte.167.12.1312 - DOI - PubMed
    1. Neufeld KJ, Leoutsakos J-MS, Yan H, et al. . Fatigue symptoms during the first year following ARDS. Chest 2020; in press [10.1016/j.chest.2020.03.059]. - DOI - PMC - PubMed

MeSH terms